Concepts (162)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amnion | 9 | 2019 | 36 | 3.590 |
Why?
|
| Epithelial Cells | 6 | 2014 | 138 | 2.090 |
Why?
|
| Regenerative Medicine | 8 | 2019 | 187 | 2.090 |
Why?
|
| Hydrogels | 5 | 2019 | 103 | 1.830 |
Why?
|
| Tissue Engineering | 9 | 2019 | 608 | 1.820 |
Why?
|
| Cystic Fibrosis | 3 | 2019 | 23 | 1.790 |
Why?
|
| Stem Cells | 5 | 2019 | 292 | 1.110 |
Why?
|
| Cell Differentiation | 6 | 2014 | 436 | 1.070 |
Why?
|
| Wound Healing | 3 | 2019 | 182 | 0.920 |
Why?
|
| Cell Separation | 2 | 2014 | 86 | 0.850 |
Why?
|
| Biocompatible Materials | 3 | 2014 | 210 | 0.810 |
Why?
|
| Animals | 21 | 2019 | 7297 | 0.720 |
Why?
|
| Bacterial Infections | 1 | 2019 | 42 | 0.690 |
Why?
|
| Immunomodulation | 1 | 2018 | 30 | 0.630 |
Why?
|
| Lung Injury | 3 | 2012 | 64 | 0.580 |
Why?
|
| Organ Transplantation | 2 | 2019 | 65 | 0.580 |
Why?
|
| Humans | 28 | 2019 | 29093 | 0.560 |
Why?
|
| Health Systems Agencies | 1 | 2015 | 2 | 0.550 |
Why?
|
| Social Responsibility | 1 | 2015 | 13 | 0.550 |
Why?
|
| Pulmonary Fibrosis | 2 | 2012 | 10 | 0.520 |
Why?
|
| Artificial Organs | 1 | 2014 | 12 | 0.500 |
Why?
|
| Cryopreservation | 2 | 2014 | 42 | 0.490 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2012 | 10 | 0.450 |
Why?
|
| Keratinocytes | 4 | 2019 | 26 | 0.450 |
Why?
|
| Printing | 1 | 2012 | 5 | 0.440 |
Why?
|
| Bioreactors | 1 | 2012 | 59 | 0.430 |
Why?
|
| Amniotic Fluid | 1 | 2013 | 84 | 0.430 |
Why?
|
| Materials Testing | 1 | 2012 | 84 | 0.430 |
Why?
|
| Placenta | 1 | 2013 | 63 | 0.430 |
Why?
|
| Mice | 9 | 2019 | 2368 | 0.400 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2013 | 161 | 0.390 |
Why?
|
| Tissue Scaffolds | 4 | 2018 | 386 | 0.370 |
Why?
|
| Lung | 2 | 2017 | 233 | 0.370 |
Why?
|
| Macrophages | 1 | 2012 | 188 | 0.370 |
Why?
|
| Stem Cell Transplantation | 5 | 2019 | 203 | 0.320 |
Why?
|
| Fibroblasts | 3 | 2019 | 103 | 0.320 |
Why?
|
| Disease Models, Animal | 6 | 2019 | 980 | 0.310 |
Why?
|
| Cytokines | 2 | 2017 | 243 | 0.270 |
Why?
|
| Bleomycin | 4 | 2013 | 10 | 0.260 |
Why?
|
| Mice, Nude | 4 | 2019 | 276 | 0.250 |
Why?
|
| Cells, Cultured | 2 | 2017 | 799 | 0.230 |
Why?
|
| Urinary Bladder | 2 | 2015 | 164 | 0.220 |
Why?
|
| Extracellular Matrix | 2 | 2015 | 226 | 0.220 |
Why?
|
| Swine | 2 | 2019 | 201 | 0.210 |
Why?
|
| Hyaluronic Acid | 2 | 2017 | 45 | 0.190 |
Why?
|
| Respiratory Mucosa | 1 | 2019 | 10 | 0.180 |
Why?
|
| Erectile Dysfunction | 1 | 2019 | 48 | 0.170 |
Why?
|
| High-Throughput Screening Assays | 1 | 2018 | 11 | 0.160 |
Why?
|
| Neurotoxins | 1 | 2018 | 16 | 0.160 |
Why?
|
| Spheroids, Cellular | 1 | 2018 | 28 | 0.160 |
Why?
|
| Blood-Brain Barrier | 1 | 2018 | 42 | 0.160 |
Why?
|
| Endothelial Cells | 1 | 2019 | 179 | 0.160 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2017 | 16 | 0.150 |
Why?
|
| Mice, Inbred C57BL | 4 | 2014 | 711 | 0.150 |
Why?
|
| Tissue Array Analysis | 1 | 2017 | 34 | 0.150 |
Why?
|
| Skin | 1 | 2019 | 203 | 0.150 |
Why?
|
| Cerebral Cortex | 1 | 2018 | 141 | 0.150 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 100 | 0.150 |
Why?
|
| Female | 7 | 2019 | 18164 | 0.150 |
Why?
|
| Cells, Immobilized | 1 | 2016 | 23 | 0.140 |
Why?
|
| Portraits as Topic | 1 | 2015 | 4 | 0.140 |
Why?
|
| Ibuprofen | 1 | 2015 | 4 | 0.140 |
Why?
|
| Dermis | 1 | 2015 | 12 | 0.140 |
Why?
|
| Nanofibers | 1 | 2015 | 4 | 0.140 |
Why?
|
| Inflammation | 1 | 2019 | 507 | 0.140 |
Why?
|
| Drug Carriers | 1 | 2015 | 16 | 0.140 |
Why?
|
| Electron Microscope Tomography | 1 | 2015 | 1 | 0.140 |
Why?
|
| Cell Nucleolus | 1 | 2015 | 2 | 0.140 |
Why?
|
| Fibroins | 1 | 2015 | 5 | 0.140 |
Why?
|
| Tomography, X-Ray | 1 | 2015 | 5 | 0.140 |
Why?
|
| Lysosomes | 1 | 2015 | 10 | 0.130 |
Why?
|
| Collagen | 2 | 2019 | 217 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 35 | 0.130 |
Why?
|
| Polyesters | 1 | 2015 | 72 | 0.130 |
Why?
|
| Plethysmography, Whole Body | 1 | 2014 | 1 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2019 | 573 | 0.130 |
Why?
|
| Biomedical Engineering | 1 | 2014 | 23 | 0.130 |
Why?
|
| Transplantation | 1 | 2014 | 12 | 0.130 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 130 | 0.130 |
Why?
|
| Forecasting | 1 | 2015 | 133 | 0.130 |
Why?
|
| Bioengineering | 1 | 2015 | 67 | 0.120 |
Why?
|
| Tracheal Stenosis | 1 | 2013 | 5 | 0.120 |
Why?
|
| Urology | 1 | 2014 | 30 | 0.120 |
Why?
|
| Mitochondria | 1 | 2015 | 174 | 0.120 |
Why?
|
| Trachea | 1 | 2013 | 55 | 0.120 |
Why?
|
| Wounds and Injuries | 1 | 2016 | 250 | 0.120 |
Why?
|
| Fetal Stem Cells | 1 | 2013 | 10 | 0.120 |
Why?
|
| Cell Transplantation | 1 | 2013 | 63 | 0.110 |
Why?
|
| Infant, Premature, Diseases | 1 | 2013 | 22 | 0.110 |
Why?
|
| Pregnancy | 2 | 2013 | 815 | 0.110 |
Why?
|
| Rats | 2 | 2019 | 1604 | 0.110 |
Why?
|
| Lung Diseases | 1 | 2013 | 45 | 0.110 |
Why?
|
| Iodine | 1 | 2012 | 3 | 0.110 |
Why?
|
| Cell Polarity | 1 | 2012 | 14 | 0.110 |
Why?
|
| Immunohistochemistry | 2 | 2015 | 519 | 0.110 |
Why?
|
| Premature Birth | 1 | 2013 | 39 | 0.110 |
Why?
|
| Social Control, Formal | 1 | 2012 | 7 | 0.110 |
Why?
|
| Transcriptional Activation | 1 | 2012 | 42 | 0.110 |
Why?
|
| Culture Media | 1 | 2012 | 39 | 0.110 |
Why?
|
| Protein Transport | 1 | 2012 | 74 | 0.110 |
Why?
|
| Cell Death | 1 | 2012 | 71 | 0.110 |
Why?
|
| Mechanical Phenomena | 1 | 2012 | 27 | 0.110 |
Why?
|
| Lymphocytes | 1 | 2012 | 53 | 0.110 |
Why?
|
| Pulmonary Surfactant-Associated Protein C | 1 | 2012 | 2 | 0.110 |
Why?
|
| Neutrophil Infiltration | 1 | 2012 | 9 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2012 | 75 | 0.110 |
Why?
|
| Actins | 1 | 2012 | 52 | 0.100 |
Why?
|
| Reconstructive Surgical Procedures | 1 | 2013 | 190 | 0.100 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2012 | 62 | 0.100 |
Why?
|
| Gene Expression | 1 | 2012 | 332 | 0.100 |
Why?
|
| Injections, Intraperitoneal | 1 | 2010 | 41 | 0.100 |
Why?
|
| Interferon-gamma | 1 | 2010 | 51 | 0.100 |
Why?
|
| Kidney | 1 | 2015 | 485 | 0.100 |
Why?
|
| Respiratory Function Tests | 1 | 2010 | 111 | 0.100 |
Why?
|
| Mice, Knockout | 1 | 2012 | 425 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 66 | 0.090 |
Why?
|
| Karyotyping | 1 | 2010 | 27 | 0.090 |
Why?
|
| Telomere | 1 | 2010 | 10 | 0.090 |
Why?
|
| Cell Cycle | 1 | 2010 | 69 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2010 | 225 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 172 | 0.090 |
Why?
|
| Flow Cytometry | 1 | 2010 | 171 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 200 | 0.090 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 167 | 0.080 |
Why?
|
| Equipment Design | 2 | 2019 | 167 | 0.080 |
Why?
|
| Time Factors | 1 | 2012 | 2001 | 0.080 |
Why?
|
| United States | 1 | 2015 | 3630 | 0.070 |
Why?
|
| Male | 3 | 2019 | 17807 | 0.070 |
Why?
|
| Allergy and Immunology | 1 | 2019 | 3 | 0.040 |
Why?
|
| Rats, Nude | 1 | 2019 | 38 | 0.040 |
Why?
|
| Skin, Artificial | 1 | 2019 | 31 | 0.040 |
Why?
|
| Microfluidics | 1 | 2017 | 15 | 0.040 |
Why?
|
| Drug Discovery | 1 | 2017 | 30 | 0.040 |
Why?
|
| Organoids | 1 | 2017 | 68 | 0.040 |
Why?
|
| Heart | 1 | 2017 | 161 | 0.040 |
Why?
|
| Heparin | 1 | 2016 | 75 | 0.030 |
Why?
|
| Gold | 1 | 2015 | 15 | 0.030 |
Why?
|
| Porosity | 1 | 2015 | 36 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2015 | 44 | 0.030 |
Why?
|
| Antibodies | 1 | 2015 | 53 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2015 | 56 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 185 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 160 | 0.030 |
Why?
|
| Respiratory Physiological Phenomena | 1 | 2014 | 6 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2015 | 114 | 0.030 |
Why?
|
| Liver | 1 | 2017 | 464 | 0.030 |
Why?
|
| Dogs | 1 | 2013 | 117 | 0.030 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2013 | 10 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2013 | 78 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2013 | 263 | 0.030 |
Why?
|
| Respiratory Rate | 1 | 2012 | 12 | 0.030 |
Why?
|
| Pulmonary Ventilation | 1 | 2012 | 11 | 0.030 |
Why?
|
| Gestational Age | 1 | 2013 | 96 | 0.030 |
Why?
|
| Tidal Volume | 1 | 2012 | 13 | 0.030 |
Why?
|
| Mice, SCID | 1 | 2012 | 71 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2013 | 598 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2013 | 327 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2015 | 348 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 1 | 2015 | 518 | 0.020 |
Why?
|
| Quality of Life | 1 | 2015 | 816 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 2019 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2013 | 2108 | 0.020 |
Why?
|